CDx Diagnostics

Curated by Signal

Provider of AI-based platform to detect precancerous tissues

Life Sciences Technologycdxdiagnostics.com

Overview

Provider of AI-based platform to detect precancerous tissues. The company uses proprietary platform technology WATS3d Biopsy to detect precancerous changes. The products of the company include OralCDx a non-invasive oral brush biopsy and EndoCDx a transepithelial laryngeal brush biopsy.

Key facts

Founded: 1997
Headquarters: Suffern, United States
Stage: Sign up to view
Industry: Life Sciences Technology

Business model

1 product or service: Sign up to view

Contact

Phone: Sign up to view

Open roles

1 role

Talent Community
United States · Remote · Full-time

More on Vanberra Signal

Members only

Business overviewCore metrics and financials PeopleLeadership and key people Similar companiesPeers and competitors Deep AnalysisAI-generated strategic report

Competitors & similar companies

More Life Sciences Technology companies

BioSensors
Non-invasive wearable device using electromagnetic impedance technologies
Life Sciences TechnologySchenectady, United States
Interlinked Therapeutics
Developer of a drug discovery platform using machine learning
Life Sciences TechnologyPortland, United States
Global Instrumentation
Developer of ECG recorder and analysis system
Life Sciences TechnologyManlius, United States

About CDx Diagnostics

What does CDx Diagnostics do?

Provider of AI-based platform to detect precancerous tissues.

Where is CDx Diagnostics headquartered?

CDx Diagnostics is headquartered in Suffern, United States.

When was CDx Diagnostics founded?

CDx Diagnostics was founded in 1997.

Which sector is CDx Diagnostics in?

CDx Diagnostics operates in Life Sciences Technology.

Who are CDx Diagnostics's competitors?

Companies similar to CDx Diagnostics include BioSensors, Interlinked Therapeutics, and Global Instrumentation.

Is CDx Diagnostics hiring?

Yes. CDx Diagnostics has 1 open role listed on Vanberra Signal.